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Previously, we found an up-regulation of tumor necrosis factor alpha (TNF)-a and an imbalance of TNF receptors in sheep experimentally
infected with bovine leukemia virus (BLV). In order to investigate the different TNF-a-induced responses, in this study we examined the
TNF-a-induced proliferative response and the expression levels of two distinct TNF receptors on peripheral blood mononuclear cells
(PBMC) derived from BLV-uninfected cattle and BLV-infected cattle that were aleukemic (AL) or had persistent lymphocytosis (PL). The
proliferative response of PBMC isolated from those cattle with PL in the presence of recombinant bovine TNF-a (rTNF-a) was significantly
higher than those from AL cattle and uninfected cattle and the cells from PL cattle expressed significantly higher mRNA levels of TNF
receptor type II (TNF-RII) than those from AL and BLV-uninfected cattle. No difference was found in TNF-RI mRNA levels. Most cells
expressing TNF-RII in PL cattle were CD5+ or sIgM+ cells and these cells showed resistance to TNF-a-induced apoptosis. Additionally, there
were significant positive correlations between the changes in provirus load and TNF-RII mRNA levels, and TNF-a-induced proliferation and
TNF-RII mRNA levels. These data suggest that imbalance in the expression of TNF receptors could at least in part contribute to the
progression of lymphocytosis in BLV infection.
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Bovine leukemia virus (BLV) is a type C retrovirus
which is genetically and structurally similar to human T-
lymphotropic virus types (HTLV) I and II (Sagata et al.,
1985). Most of the infected cattle do not show any clinical
signs of the disease and are referred to as aleukemic (AL)
(Burny et al., 1988). Approximately 30% of cattle naturally
infected with BLV develop persistent lymphocytosis (PL)
with non-malignant polyclonal expansion of CD5+ B-cell,
the majority of which harbors BLV provirus (Mirsky et al.,
1996). After a latency period of 1–8 years, only 1–5% of0042-6822/$ - see front matter D 2005 Elsevier Inc. All rights reserved.
doi:10.1016/j.virol.2005.06.010
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E-mail address: konnai@vetmed.hokudai.ac.jp (S. Konnai).the infected cattle develop malignant B-cell lymphosarcoma
(LS) (Schwartz and Levy, 1994). Thus, the progression of
BLV infection is divided into three stages: AL, PL and LS.
Although the pathogenesis of infection clearly involves
immunoregulatory host factors, including expression of the
cytokines (Kabeya et al., 2001a), the exact mechanism of
the disease progression from AL to PL or LS in BLV-
infected cattle is not yet known.
A knowledge of which cytokines are related to the
disease progression in infected animals is important for
understanding the biology of the virus and the pathogenesis
of BLV-associated diseases. To date, several cytokines have
been reported to be associated with disease progressions of
BLV infection, such as interleukin (IL)-2, IL-4, IL-10, IL-
12, interferon (IFN)-g (Keefe et al., 1997a, 1997b, Pyeon05) 239 – 248
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1998; Trueblood et al., 1998; Amills et al., 2002; Konnai et
al., 2003a) and tumor necrosis factor (TNF)-a (Kabeya et
al., 1999, 2001b). In the previous studies, we found that the
expression of TNF-a and its receptors closely associated
with disease progression in sheep experimentally infected
with BLV (Kabeya et al., 1999, 2001b). Interestingly, we
found conflicting roles of TNF-a in sheep experimentally
infected with BLV. The TNF-a mRNA expression was
significantly up-regulated in BLV-resistant sheep; however,
down-regulation of TNF-a was found in susceptible sheep
(Kabeya et al., 1999). Most recently, Muller and co-workers
reported the lack of TNF-a supported persistence of BLV
infection in TNF/ mice (Mullar et al., 2003). These
results suggest that in the early phase of infection, TNF-a
may contribute to the elimination of BLV. In contrast, TNF-
a strongly induced the proliferative response of PBMC in
sheep with higher level of BLV in late phase of infection,
and mRNA expression of TNF receptor type I (TNF-RI) of
these sheep was down-regulated compared to BLV-negative
sheep (Kabeya et al., 2001b). These finding suggest the
imbalance of TNF receptors contribute to the progression of
the disease in BLV-infected animals. However, the mech-
anism for such proliferation and the phenotypes of the cells
expressing the TNF receptors remained obscure.
TNF-a is a multifunctional cytokine produced by several
kinds of cells and its activity is mediated by two function-
ally different cell surface receptors, TNF-RI (55 kDa) and
TNF-RII (75 kDa) (Hohmann et al., 1989). Both TNF-RI
and -RII are co-expressed in several different tissues and the
conflicting activities of TNF-a, including induction and
suppression of apoptosis, are thought to be triggered via
these two receptors. Most biologic responses of TNF-a such
as induction of cell death via apoptosis, cytokine production
and cytotoxicity are mediated by TNF-RI. However, recent
data have demonstrated that TNF-RII is able to mediate
TNF biological activity independently (Grell et al., 1998;
Haridas et al., 1998). Due to the lack of intracellular death
domain, TNF-RII is involved in the proliferation of
thymocytes and the murine cytotoxic T-cell line, and in
the TNF-dependent proliferative response of human mono-
nuclear cells (Gehr et al., 1992; Grell et al., 1998; Tartaglia
and Goeddel, 1992; Tartaglia et al., 1991; Vandenabeele et
al., 1992). TNF-RII signaling appears to be mainly confined
to cells of the immune system that makes it of high
relevance in understanding immune processes involved in
viral infections. Both receptors can bind to TNF with high
affinity, but the exact role of the two receptors in mediating
the effects of TNF and viral infections is still debated
(Herbein and O’Brien, 2000). Several investigations have
revealed the relationships between TNF or its receptors and
several diseases. The change in the expression patterns of
these TNF receptors can determine whether the cells
undergo apoptosis or proliferate as in leukemia or lym-
phoma (Gibbons et al., 1994; Waage et al., 1992). In viral
infection, TNF and TNF receptors usually have beenconsidered a main component of antiviral activity, often
acting synergistically with IFN-g. However, in recent years,
growing evidence has shown that both DNA and RNA
viruses can interfere with the TNF/TNFR pathway to escape
immune surveillance (Guidotti and Chisari, 2000; Herbein
and O’Brien, 2000). These observations raise the possibility
that the differences in TNF receptors expression could result
from differences in BLV disease progression, especially the
development of LS and PL. However, limited information is
available concerning the roles of TNF and its receptors on
the progression of disease in BLV-infected animals. In the
present experiment, to clarify the role of TNF and its
receptors on the disease progression of the BLV infection,
we examined the expression of TNF receptors, phenotypes
of cells expressing TNF receptors and the ability of TNF-a
to induce apoptosis or proliferative response in BLV-
infected cattle at two subclinical stages of infection, AL
and PL. We showed that imbalance in expression of TNF
receptors could result from differences in the disease
progression of BLV infection.Results
Up-regulation of TNF-RII expression in PBMC derived from
PL cattle
In order to investigate the differences in the expression
levels of the TNF receptors in BLV-infected cattle at
different disease stages, we used real-time PCR to quantify
the expression of TNF-RI and TNF-RII mRNAs in fresh
PBMC isolated from normal, AL and PL cattle (Fig. 1). In
contrast to the previous study of sheep, no difference in the
expression levels of TNF-RI mRNA was observed among
the different stages of BLV infection in cattle (Fig. 1A).
However, the mean expression level of TNF-RII mRNA in
PBMC isolated from PL cattle (0.99 T 0.54) was signifi-
cantly higher than that of uninfected cattle (0.44 T 0.24, P <
0.01), determined by a one-tailed Student’s t test (Fig. 1B).
Similarly, the mean expression level of TNF-RII mRNAwas
significantly increased in AL (0.71 T 0.54) compared to
BLV-negative cattle (P < 0.05). The PL stage is charac-
terized by a polyclonal expansion of B lymphocytes co-
expressing CD5+ and surface immunoglobulin M+ (sIgM)
molecules. To test for differences in the expression protein
levels of the TNF receptors, we measured the proportions of
TNF receptors expressing cells by flow cytometry. A limited
number of cattle were tested, yet as expected, the proportion
of TNF-RII+ cells was clearly increased in PL cattle
compared to AL- and BLV-negative cattle (Table 1).
Significant expansions of the CD5+TNF-RII+ (P < 0.05)
and sIgM+TNF-RII+ cell (P < 0.001) population were
detected in cattle with PL, but with variable contributions to
the overall proliferation of total TNF-RII+ cells. Concerning
the percentages of the CD4+TNF-RII+, CD8+TNF-RII+,
WC1+TNF-RII+ and CD25+TNF-RII+ cells, each BLV-
Fig. 1. Quantification of the expression of TNF receptors mRNA (A: RI, B:
RII) in PBMC by real-time PCR analysis. Individual dots indicate nineteen
BLV-uninfected (empty circle), thirty-two AL (full circles) and twenty-one
PL (full diamonds) cattle, respectively. The results were shown as the ratios
obtained by dividing the concentrations of the PCR products from the TNF
receptors mRNAs by the dose from the h-actin mRNA. Each line in the dots
indicates the mean mRNA levels in each group. Differences between groups
were considered significant if probability values of P < 0.05 were obtained.
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tion, but numbers of these cells were also significantly
increased between PL cattle and controls. In contrast to
TNF-RII protein levels, no difference in the expression
levels of TNF-RI was observed among the stages of BLV
infection (data not shown). The results obtained from the
flow cytometric analysis were consistent with the results
from real-time PCR for the quantification of TNF-RII
mRNA in the PBMC mentioned above.
Provirus loads and TNF-RII expression
To evaluate the association of the TNF-RII expression
with viral propagation in BLV-infected individuals, theprovirus loads were determined in BLV-infected cattle with
PL and AL by real-time PCR system. The provirus load was
significantly increased in the cattle with PL (18.6 T 12.1%)
compared to cattle with AL (7.9 T 10.0%, P < 0.0001). To
determine if this increased expression of TNF-RII mRNA
correlated to provirus loads, we statistically analyzed with
Pearson correlation coefficients (Fig. 2). Significant positive
correlations between the provirus loads and TNF-RII mRNA
levels were detected (r = 0.425229, P < 0.01). Thus, this
result suggests that up-regulation of TNF-RII expression
could influence the expansion of BLV-infected cells during
the disease progression from AL to PL. To check this
possibility, we further examined if the expression of TNF-RII
is specifically up-regulated in BLV-infected cells by inves-
tigating the proportions of TNF-RII+p24+ cells in fresh
PBMC by flow cytometry. However, BLV-p24+ cells were at
low detectable levels in the PBMC freshly isolated from PL
cattle (data not shown). In addition, to analyze the association
between TNF-RII expression and BLV regulatory gene
product, Tax, we investigated the Tax mRNA expression in
cattle that were staged as AL or PL. Tax plays an important
role in BLVand HTLV-I pathogenesis because Tax is thought
to up-regulate several cellular genes including cytokines and
their receptors. However, no detectable expression of BLV
Tax was observed in fresh PBMC containing cells expressing
high levels of TNF-RII when RNA transcription of the BLV-
tax gene was analyzed (data not shown).
Resistance to TNF-a-induced apoptotic death in PBMC
from PL cattle
To evaluate whether BLV infection can modulate the
susceptibility of PBMC to TNF-a-induced apoptosis, we
examined the percentages of specific apoptosis by bovine
rTNF-a in PBMCderived from cattlewithAL-, PL- andBLV-
uninfected cattle. As shown in Fig. 3, PBMC fromAL (54.5 T
15.2%) and control (63.7 T 13.1%) cattle were susceptible to
TNF-a-induced apoptosis. In contrast, the mean percentage
of specific apoptosis in PL cattle (25.0 T 17.8%) was
significantly lower than that in AL (P < 0.001)- or BLV-
negative cattle (P < 0.001). A combination of both rIL-2 and
rTNF-a allowed a synergistic effect and reduced the level of
apoptosis in PL cattle (9.5 T 13.2%), although there were no
marked effect in control (60.8 T 14.1%) and AL (47.3 T
17.0%) cattle. The mean of specific apoptosis was signifi-
cantly reduced in the combination of both rIL-2 and rTNF-a
compared to rTNF-a alone in PBMC from PL cattle (P <
0.05). The results show that the TNF-RII high expressing
PBMC from PL cattle are resistant to TNF-a-induced
apoptosis and the reaction is enhanced by presence of IL-2.
High proliferative responses to bovine rTNF-a in PBMC
from PL cattle
To test if differences in the expression levels of the TNF
receptors contribute to the TNF-a-induced proliferative
Table 1
Subpopulations of TNF-RII-expressing cells in control and BLV-infected cattle with AL and PL
Disease
stagea
No.
of
cattle
No. of
lymphocyte
(/mm3)
RII/RI
ratio
No. (%) of lymphocyte (/mm3)
CD4+ RII+ CD8+ RII+ WC1+ RII+ CD25+ RII+ CD5+ RII+ sIgM+ RII+
Controls 8 3661 T 1030 1.2 T 0.3 117 T 174
(4.4 T 2.5)
124 T 32
(3.5 T 0.6)
145 T 50
(4.2 T 1.7)
170 T 64
(5.3 T 2.1)
41 T 10
(1.2 T 0.4)
55 T 26
(1.7 T 1.2)
AL 13 4728 T 1063 1.2 T 0.4 280 T 204*
(5.8 T 4.1)
192 T 69
(4.2 T 1.4)
155 T 79
(3.3 T 1.6)
356 T 320
(6.1 T 2.7)
82 T 38**
(1.7 T 0.7)
42 T 20
(0.9 T 0.3)
PL 11 14,282 T 2608 1.9 T 1.2 729 T 626**
(5.8 T 4.2)
532 T 248**
(4.8 T 3.8)
681 T 678*
(6.0 T 4.7)
1058 T 711***
(8.5 T 4.9)
2229 T 2322*
(18.0 T 17.1)
2010 T 1394***
(16.4 T 11.7)
a Animals were regarded as positive for PL if at least two consecutive lymphocyte counts was more than 10,000/mm3.
* P < 0.05; comparisons are between BLV-infected cattle and control cattle and were established with a Student’s t test.
** P < 0.01; comparisons are between BLV-infected cattle and control cattle and were established with a Student’s t test.
*** P < 0.001; comparisons are between BLV-infected cattle and control cattle and were established with a Student’s t test.
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we examined the proliferative response to bovine rTNF-a in
PBMC derived from cattle with AL-, PL- and BLV-
uninfected cattle (Table 2). The means proliferative
responses to rTNF-a were higher in BLV-infected cattle
compared to BLV-negative cattle, although there were some
individual exceptions. The mean stimulation index (SI) of
proliferative responses to rTNF-a in cells from BLV-
negative cattle was approximately 2.3, and this mean was
five times higher in PL cattle (SI = 10.8). The mean
proliferative response in PL cattle was significantly higher
than that in AL (SI = 6.4, P < 0.05) or BLV-negative cattle
(P < 0.01). Similarly, the mean proliferative response to
rTNF-a was significantly increased in AL- compared to
BLV-negative cattle (P < 0.05, Fig. 4A). To confirm the
ability of cell proliferation, we assayed with several
mitogens, namely, LPS, Con A and PWM (Table 2).
Although the mean response with LPS was no significant
difference, response to Con A and PWM were higher in
BLV-negative cattle than those of BLV-infected cattle. There
was also no significant difference in the response to
mitogens between AL and PL cattle. Thus, these results
suggest that the ability of cells to proliferate in response to
TNF-a increases in BLV-infected cattle. To determine if this
increased expression of TNF-RII mRNA correlated to TNF-
dependent proliferation, we statistically analyzed with
Pearson correlation coefficients (Fig. 4B). Significant
positive correlations between the TNF-a-induced prolifer-
ation and TNF-RII mRNA levels were detected (r =
0.474153, P < 0.0001). Thus, these results suggest that
up-regulation of TNF-RII expression could influence the
proliferation of cells during disease progression, such as PL.Fig. 2. Correlation of the provirus load and TNF-RII mRNA expression in
BLV-infected cattle. The percentages of BLV-positive cells were determined
using a system for real-time quantitative PCR. Results of expression levels
of TNF-RII mRNA are corresponded to Fig. 1B. Individual dots indicate 32
AL (A) and 21 PL (B) cattle, respectively. Statistical analyses were
performed with Pearson correlation coefficients.Discussion
TNF has a unique role in regulating the immune response
to viral infections after its binding to the specific receptors,
TNF-RI and TNF-RII, and the susceptibility to viral
infection and development of the disease was shown to be
determined by TNF-induced functions, and linked to theTNF receptors (Guidotti and Chisari, 2000; Herbein and
O’Brien, 2000). In BLV-infected sheep, a good correlation
was observed between up-regulation of TNF-a and BLV
Fig. 3. Susceptibility of PBMC to TNF-a-induced apoptosis in BLV-infected cattle at different disease stages. Individual dots indicate eight BLV-uninfected
(empty circle), thirteen AL (full circles) and eleven PL (full diamonds) cattle, respectively. Tested cattle correspond to Table 1. All samples were cultured for
48 h in the presence of human rIL-2 (1 U/ml) or bovine rTNF-a (40 Ag/ml) or mixture of rIL-2 and rTNF-a. The cell were stained with 7-AAD and the
apoptotic cells were analyzed by flow cytometer. The data represent the percentage of apoptotic cells after each treatment from which background apoptosis
(medium only) is subtracted. Line in the dots indicates the mean percentage of specific apoptosis in each group. Differences between groups were considered
significant if probability values of P < 0.05 were obtained.
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that the imbalanced expression of the TNF receptors is
responsible for the conflicting TNF-induced responses in
BLV infection. In the present study, to evaluate this
possibility, we monitored the expression of TNF receptors
during the different stages of BLV infection, and found
significantly different expression levels of TNF-RII in
PBMC from cattle with in the PL stage of BLV infection
when compared to those with the AL stage or normal
controls. We also found higher anti-apoptosis activity and
proliferative responses to rTNF-a in PBMC-expressing
TNF-RII isolated from PL cattle than that from uninfected
cattle. Con A, a lectin that induces T-cell proliferation by
specific interaction with the T-cell receptor complex and a
strong inducer of cell proliferation in normal bovine
PBMCs, was used as a control for cell proliferative
response. Further, PWM, which is a B-cell mitogen, was
used as the cell division stimulant. However, our observa-
tions indicated that the proliferative responses to these
mitogens were lower in PL cattle than in BLV-negative
cattle, consistent with the previously reported observations
(Ferens and Hovde, 2000). Notwithstanding these observa-
tions, we found that TNF-a strongly induced the prolifer-
ative response of PBMC in cattle with PL in late phase ofinfection. These observations raise the possibility that the
differences in TNF-a-dependent proliferative responses
could result from differences in the expression pattern of
TNF receptors.
Although the role of TNF-RII in the tumorigenesis of the
BLV-induced PL is still speculative, the TNF receptor
superfamily including Fas, CD27, CD30, TNF-RI and
TNF-RII is a group of cell surface proteins involved in
differentiation, activation, proliferation and apoptosis of cells
(Smith et al., 1994). The proliferation of activated peripheral
lymphocytes can be enhanced by TNF-a and also with TNF-
RII mAb (Tartaglia et al., 1993; Yokota et al., 1988),
suggesting that TNF-RII is mainly responsible for the
proliferative effects of TNF-a in cells. TNF-receptor-
associated factor 2 (TRAF-2) homodimers and TRAF-1-
TRAF-2 heterodimers can associate with the C-terminal
region in cytoplasmic domain of TNF-RII, which is required
for signaling, proliferation and activation of nuclear factor-
nB (NF-nB) (Rothe et al., 1994, 1995a). Inhibitor of
apoptosis proteins c-IAP1 and c-IAP2 associates withTRAF1
and TRAF2 as part of the TNF-RII signaling complex and can
inhibit apoptosis by directly affecting the down proteases
caspase-3 and caspase-7 (Rothe et al., 1995b; Roy et al.,
1997). Previously, we observed that TNF-a strongly induced
Table 2
PBMC proliferative responses in control and BLV-infected cattle with AL and PL
Disease stage No. of cattle Stimulation index (mean T SD)a
rTNF-a (40 Ag/ml) LPS (25 Ag/ml) Con A (5 Ag/ml) PWM (1 Ag/ml)
Controls 20 2.3 T 3.4 2.5 T 2.9 341.3 T 264.9 51.6 T 39.4
AL 32 6.4 T 5.0* 2.4 T 2.3 117.7 T 103.9** 35.6 T 37.7
PL 21 10.8 T 7.7** 3.7 T 4.5 93.0 T 99.2** 27.7 T 19.4**
a All samples were tested in triplicate, and the stimulation index was defined as mean counts of test samples divided by mean counts of controls.
* P < 0.05; comparisons are between BLV-infected cattle and control cattle and were established with a Student’s t test.
** P < 0.01; comparisons are between BLV-infected cattle and control cattle and were established with a Student’s t test.
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BLV in the late phase of infection, and then mRNA
expression of TNF-RI was down-regulated in PBMC from
the sheep with high levels of BLV compared to BLV-negative
sheep (Kabeya et al., 2001a, 2001b). In the present experi-
ment, we observed the up-regulation of TNF-RII expression
on PBMC from PL cattle, although we could not observe a
significant different expression of TNF-RI on PBMC in BLV-
infected cattle. The difference was not statistically significant
possibly due to the limited numbers of subjects available or
because of a variable infectious period. One possible
explanation for the enhanced anti-apoptosis activity and high
proliferative response to TNF-a in PBMC isolated from PL
relates to the different kinetics of signaling by imbalance of
TNF receptors, such as down-regulation of TNF-RI or up-
regulation of TNF-RII, although the exact mechanism in the
regulations of TNF receptors expression is still not clear.
Further analysis of activation of NF-nB or protease caspase in
relation to the different expression of TNF receptors is
required to clarify this point. Our results suggest that the
imbalance of TNF receptors could influence the apoptosis
and proliferation of cell during the disease progression from
aleukemic stage to lymphocytosis.
Interestingly, increased expression of TNF-RII but not
TNF-RI have been also reported in a BLV-infected B cell
line, KU-1 (Kabeya et al., 2001a, 2001b) and HTLV-I-
infected T-cell lines (Yang et al., 2002). Indeed, Yang et al.
(2002) reported the HTLV-I-infected cell lines expressing
TNF-RII were resistant to TNF-a-mediated apoptosis. In the
present experiment, the TNF-RII high expressing PBMC
from PL cattle are strongly resistant to TNF-a-induced
apoptosis and the reaction is enhanced by presence of IL-2.
These findings suggest that similar responses such as
resistance to apoptosis of the cells might occur in TNF-
RII-expressing cell lines derived from HTLV-I-infected
patients and BLV-infected-cell lines. Additionally, at the
PL stages, increased population of CD5+ B-cells expressed
higher levels of TNF-RII. Trueblood et al. (1998) found B-
cell proliferation during BLV-induced PL was enhanced by
T-cell-derived IL-2. Although IL-2 may be a major factor
for cell proliferation, TNF-a, as shown in the case of the
proliferation of PBMC in this study, is also likely to play a
role in proliferation on retroviral infections such as BLV or
HTLV-I. It has been proposed that the expression of CD25
as IL-2 receptor and IL-2/CD25 autocrine or paracrine loopplay a part in maintaining the very high proviral loads often
found in BLV infection (Stone et al., 1994, 1995, 1997;
Trueblood et al., 1998). Indeed, at the PL stages, increased
population of CD25+TNF-RII+ cells was observed in the
present experiment. Furthermore, it is possible that the
increased expression of TNF-RII may assist the IL-2-
induced cell proliferation by anti-apoptosis and contribute
to the development of lymphocytosis or lymphoma in BLV-
infected animals (Fig. 5).
In HTLV-I infection, aberrant production of several
cytokines and their receptors was thought to be a result of
the transactivating ability of the Tax protein of HTLV-I
(Uchiyama, 1997; Leung and Nabel, 1988; Ballard et al.,
1988; Nakajima et al., 1993). These observations raise the
possibility that the up-regulation of TNF-RII expression
might be mediated by transactivation through the BLV
regulatory gene product, Tax. To check this possibility, the
RNA transcript of BLV-tax gene was analyzed in TNF-RII
high expressing cell. However, no detectable expression of
BLV Tax was observed in fresh PBMC containing cells
expressing high levels of TNF-RII when RNA transcription
of the BLV-tax gene was analyzed (data not shown). In
addition, we failed to confirm the specific expression of
TNF-RII on BLVp24-expressing cells, although more
studies need to be conducted (data not shown). At present,
it is difficult to determine whether the expression of TNF-
RII is specifically up-regulated via virus expansion after
infection by BLV, despite its clear effect on the provirus
load. As alternative expression for the up-regulation of
TNF-RII, the mechanism by which up-regulation of TNF-
RII expression might be mediated by IFN-g. Interestingly,
the expression of TNF-RII but not of TNF-RI was up-
regulated significantly after IFN-g treatment, and rescues
TNF-a-induced apoptosis (Horie et al., 1999). IFN-g is of
central importance in viral dynamics because, along with
other cellular immunity-associated cytokines, it is thought to
be a protective factor in the progression of BLV infection.
Indeed, up-regulation of IFN-g mRNA has been reported
after infection of BLV (Keefe et al., 1997a, 1997b;
Yakobson et al., 1998; Konnai et al., 2003a). Although this
is in contrast to the previous reports that IFN-g is effective
in viral elimination, indirect effects of IFN-g may assist
TNF-a-induced proliferation via TNF-RII. The mechanism
of the up-regulation of TNF-RII during the disease
progression from AL to PL, however, remains unknown.
Fig. 4. (A) Proliferative responses of PBMC to recombinant bovine TNF-a
in BLV-infected cattle at different disease stages. Individual dots indicate
nineteen BLV-uninfected (empty circle), thirty-two AL (full circles) and
twenty-one PL (full diamonds) cattle, respectively. All samples were tested
in triplicate. The data were presented as mean stimulation index (SI: defined
as mean counts of test sample divided by mean counts of control) in each of
cattle. Line in dots indicates the mean SI in each group. Differences
between groups were considered significant if probability values of P <
0.05 were obtained. (B) Correlation of the TNF-RII mRNA expression and
proliferative response to bovine rTNF-a. Results of expression levels of
TNF-RII mRNA and rTNF-a-induced proliferation correspond to Figs. 1A
and 4A. Statistical analyses were performed with Pearson correlation
coefficients.
Fig. 5. The possible involvement of TNF receptors in the course of BLV
infection.
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TNF-RII, anti-apoptotic activity and a high proliferative
response of PBMC to TNF-a in PL cattle. TNF-a-induced
proliferative response via anti-apoptosis through its binding
to TNF-RII might contribute to the progression of bovine
leukosis in animals which develop persistent lymphocytosis
of B cells. It is possible that TNF-RII is at least one of the
proliferative-associated molecules during BLV infection
since lymphocytes from the PL stages of cattle expressed
higher levels of TNF-RII as seen in chronic lymphocyticleukemia (Trentin et al., 1994; Waage et al., 1992), Epstein–
Barr virus-transformed B cells and Burkitt lymphoma
(Gibbons et al., 1994) and HTLV-I infection (Yang et al.,
2002). Further studies are required to clarify the mechanism
in more detail to understand why the different expressions
of TNF receptors were observed in BLV-induced disease
progressions and to determine whether the expression of
TNF-RII is specifically up-regulated on BLV-infected cells.Materials and methods
Animals and BLV detections
The cattle were maintained within the Iwate university-
associated farm or the animal research center of Hokkaido
dairy herd research herd, and all were naturally infected
with BLV. BLV infection was tested by an agar gel
immunodiffusion test with gp51 as antigen (Onuma et al.,
1975) and was further confirmed by PCR with a primer pair
(BLV-LTR1; 5V-TAA TAC GAC TCA CTA TAT AGG G-3V
and BLV-LTR533; 5V-GCC GCT CTA GAA CTA GTG
GAT CCC-3V) to amplify the BLV long terminal region
(LTR) using a thermal cycler (System 9700, Applied
Biosystems) as described previously (Tajima et al., 1998).
BLV-positive animals were classified as AL or PL according
to numbers of leukocytes and percentage of lymphocytes in
whole blood (Thurmond et al., 1990). Animals were
regarded as PL if at least two consecutive leukocyte counts
including lymphoid cells were more than 10,000/Al.
Percentage of BLV-infected cells was calculated from
genomic DNA using real-time PCR as described previously
(Tajima et al., 2003). Real-time PCR using SYBER Green I
was performed using a LightCyclerTM (Roche Diagnostics)
according to the manufacturer’s instructions. Following
genomic DNA extraction from PBMC with a Wizard
DNA purification kit (Promega) as previously described
(Konnai et al., 2003b), DNA templates were suspended in
20 Al (total volume) of PCR buffer, to which had been added
S. Konnai et al. / Virology 339 (2005) 239–248246oligonucleotide primers (final concentration of 0.2 AM;
BLV-LTR primer, 256; 5V-GAG CTC TCT TGC TCC CGA
GAC-3V and BLV-LTR453; 5V-GAA ACA AAC GCG GGT
GCA AGC CAG-3V or h-globin primer as control, PC03; 5V-
ACA CAA CTG TGT TCA CTA GC-3V and PC04; 5V-CAA
CTT CAT CCA CGT TCA CC-3V), and 2 Al of LightCycler-
DNA Master SYBER Green I (Roche Diagnostics). Addi-
tionally, to determine whether Tax, a transcriptional activator
encoded by the X-region of BLV, was expressed, RT-PCR
was performed using RNA samples prepared from fresh
PBMC from BLV-infected cattle as described previously
(Tajima et al., 2003). Total RNA was extracted from the
freshly separated PBMC by using the TRIZOLTM reagent
according to the manufacturer’s protocol (Invitrogen). All
samples were treated with deoxyribonuclease I (amplifica-
tion grade, Invitrogen) to eliminate DNA contamination. The
reverse transcriptase (RT) reaction was performed with 5 Ag
of purified total RNA. BLV tax and cellular h-actin cDNA
were amplified by PCR using thermal cycler with primers
BLV tax/rex 4758 (5V-AGG CGC TCT CCT GGC TAC TG-
3V) and BLV tax/rex 7333 (5V-GGC ACC AGG CAT CGA
TGG TG-3V) and boh-actin F (5V-CGC ACC ACT GGC ATT
GTC AT-3V) and boh-actin R (5V-TCC AAG GCG ACG
TAG CAG AG-3V), respectively.
Quantitation of TNF receptor mRNAs by real-time PCR
Total RNA extraction from the freshly separated PBMC,
cDNA synthesis and real-time quantitative RT-PCR were
performed as described previously (Konnai et al., 2003a).
The cDNA template was mixed with a total volume of 20 Al
of PCR buffer with oligonucleotide primers (0.2 mM each,
final conc.), either boTNF-RI F (5V-CGC CTC TGT CGT
CTT AGC AT-3V) and boTNF-RI R (5V-TGG AGA CAG
GAC TGG AAC TT-3V), or boTNF-RII F (5V-CTC GAC
CAG CAG CAC GGA CA-3V) and boTNF-RII R (5V-GCG
TCT GTG TCC CTC GTG GA-3V), and 2 Al of SYBER
Green I (Roche Diagnostics) was added. We also amplified
the bovine h-actin gene in each sample, using a primer pair,
boh-actin F (5V-CGC ACC ACT GGC ATT GTC AT-3V) and
boh-actin R (5V-TCC AAG GCG ACG TAG CAG AG-3V)
to monitor the concentrations of template cDNAs.
Flow cytometry analysis
To analyze the cells expressing TNF receptors, single-
and dual-color flow cytometric analysis was performed
using the following antibodies: IL-A11 (mouse anti-bovine
CD4), CACT105A (mouse anti-bovine CD5, VMRD), IL-
A51 (mouse anti-bovine CD8), IL-A29 (mouse anti-bovine
WC1), IL-A111 (mouse anti-bovine CD25; IL-2R), IL-A30
(mouse anti-bovine surface IgM), H-202 (rabbit anti-human
TNF-RI; Santa Cruz Biotechnology), H-202 (rabbit anti-
human TNF-RII; Santa Cruz Biotechnology) and BLV3
(mouse anti-BLV p24, VMRD) as described previously
(Dequiedt et al., 1997; Konnai et al., 2003c). PurifiedPBMC (1  107 cells/ml) were incubated with the optimal
concentration of each antibody for 30 min at 4 -C. Then, the
cells were washed with sterile PBS containing EDTA (0.75
mg/ml) and labeled with isotype-specific secondary anti-
bodies, fluorescein isothiocyanate (FITC)-conjugated goat
anti-rabbit immunoglobulins (Immunotech) or phycoery-
thrin (PE)-conjugated goat anti-mouse immunoglobulins
(Immunotech). Fluorescence of the cells was measured on
an EPICS XL, and the data were analyzed using the
SYSTEM IITM software (Beckman Coulter).
Induction of apoptosis and detection of apoptotic cells
Since the percentage of apoptotic cell in PBMC (5  105/
ml) from healthy cattle by bovine recombinant TNF-a (40
Ag/ml, rTNF-a; a gift from Dr. Yuichi Yokomizo, National
Institute for Animal Health, Tsukuba, Japan) in 48-h culture
was dose dependent and plateaued at 50 Ag/ml, the PBMC
derived from cattle with PL and AL or controls were
cultured under a concentration of 40 Ag/ml. To further
investigate the combined effects of IL-2 that were thought to
be a major proliferative factor in BLV infection, cells were
incubated with the optimal concentration of human
recombinant IL-2 (rIL-2, 1U/ml, Wako Chemicals) which
was added simultaneously as described previously (True-
blood et al., 1998). Apoptosis was measured after 48 h
cultivation with various treatments. To measure apoptosis,
we used the DNA dye 7-aminoactinomycine D (7-AAD) as
described previously (Yang et al., 2002). Briefly, after cell
surface labeling, cells were incubated with 7-AAD (20 Ag/
ml) (Immunotech) in PBS in the dark for 20 min at room
temperature, washed twice in PBS and fixed in 1%
paraformaldehyde solution containing actinomycin D (AD)
(20 Ag/ml). The samples were submitted for flow cytometry
analysis in a paraformaldehyde AD solution. Ten thousand
events were acquired, and apoptotic cells were analyzed
using EPICS XL with SYSTEM IITM as above. The
apoptotic cells were calculated as described previously
(Yang et al., 2002). % specific apoptosis = (% 7-AAD+ cells
in the medium containing rTNF-a  spontaneous 7-AAD+
cells in the medium alone) / (100 % spontaneous 7-AAD+
cells in the medium alone)  100.
Proliferation assay
In order to investigate the influence of TNF-a on TNF-
receptor-expressing cell proliferation, we monitored prolif-
erative response to bovine rTNF-a. PBMC (105 cells/well in
96-well flat-bottom) isolated from PL, AL and control
animals were cultured at 37 -C for 72 h with 5% CO2 in the
presence of rTNF-a (40 Ag/ml), lipopolysaccharide (LPS;
50 Ag/ml, Sigma), concanavalin A (Con A; 5 Ag/ml, Sigma)
and pokeweed mitogen (PWM; 1 Ag/ml, Gibco) in a final
volume of 200 Al as described previously (Kabeya et al.,
2001b). [3H]-Thymidine (0.5 ACi/well) was added to the
culture and cultured for an additional 6 h, then the cells were
S. Konnai et al. / Virology 339 (2005) 239–248 247harvested onto glass filters and incorporated radioactivity
was measured by liquid scintillation counter. All samples
were tested in triplicate, and the data were presented as
mean stimulation index (SI: defined as mean counts of test
samples divided by mean counts of controls).
Statistical analysis
Data were analyzed by one-way analysis of variance
followed by Student’s t test. Differences between groups
were considered significant if probability values of P < 0.05
were obtained. To evaluate the relationships between
provirus loads and TNF-RII mRNA levels, and TNF-a-
induced proliferation and TNF-RII mRNA levels, Pearson
correlation coefficients were calculated as described pre-
viously (Waldvogel et al., 2000). All statistical analyses
were performed with the statistical software StatceL (OMS,
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